“The FDA Emergency Use Authorization of molnupiravir is a vital milestone while in the combat versus COVID-19, and adds to Merck’s legacy of bringing ahead innovative medicines that both equally handle the whole world’s biggest health threats and aid save life. Since we recognized the promise of molnupiravir early, Merck https://apilimodmesylate65431.shotblogs.com/this-article-is-under-review-42055878